New study has implications for treating and preventing cancers caused by viruses
New research from the Trudeau Institute addresses how the human body controls gamma-herpesviruses, a class of viruses thought to cause a variety of cancers. The study, carried out in the laboratory of Dr. Marcia Blackman, awaits publication in The Journal of Immunology. Led by postdoctoral fellow Mike Freeman, with assistance from other laboratory colleagues, the study describes the role of white blood cells in controlling gamma-herpesvirus infections and has implications for the treatment and prevention of certain cancers.
One of the many factors that can contribute to the development of cancer is infection with cancer-causing viruses, among them gamma-herpesviruses like the Epstein Barr virus and Kaposi's sarcoma-associated herpesvirus. With more than 95 percent of the human population infected with one or both of these viruses, it is important to understand their infection cycles and how immune responses keep them in check in the majority of individuals.
Gamma-herpesvirus infections are characterized by two distinct phases. In the initial, active phase, the immune system responds by attacking the virus. The virus, however, has developed a clever mechanism for "sneaking" past the immune response to conceal itself within the body, a process researchers refer to as latent infection. While in hiding, the virus persists in a quiet, inactive state. Occasionally, it can start to reactivate and begin to multiply again, increasing the risk of cancer development.
The chance that cancer will develop is greatly increased if the immune system is weakened, such as with immunosuppression following transplantation or as a consequence of other diseases, such as AIDS.
Researchers around the globe are asking important questions about the nature of these viruses and working in their labs to answer them. Among those questions: How do the viruses escape the immune response to establish lifelong latency? What triggers their reactivation in some people? Can we develop therapies to control reactivation and prevent the development of cancer?
The key finding of the Blackman study is that the mechanism by which a type of white blood cell, called a CD8 T cell, controls the virus differs between the initial active phase of infection and long-term latent infection. These novel findings will accelerate efforts to develop therapies to control gamma-herpesvirus infections and prevent the development of virus-associated cancers.
Journal reference:
Journal of Immunology
Provided by
Trudeau Institute
-
Herpes virus: To vaccinate or not to vaccinate
Feb 12, 2009 |
not rated yet |
0
-
Viral evasion gene reveals new targets for eliminating chronic infections
Jan 05, 2011 |
not rated yet |
0
-
Targeting hit-and-run cancer viruses
Aug 18, 2010 |
not rated yet |
0
-
Scientists tackle viral mysteries
Jun 29, 2009 |
not rated yet |
0
-
Scientists discover 'traitor' human DNA helps viruses cause cancer
Apr 26, 2010 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Question of reflection and transmission of TEM wave in normal incidenc
2 hours ago
-
the rudyak-krasnolutski effective potencial
3 hours ago
-
Normal force for a lever model
4 hours ago
-
gravity is std. therefore can we rate a 'mass at height' by watts?
10 hours ago
-
Calculating on-axis elements of a solenoid
22 hours ago
-
latitude & longitude & air pressure
23 hours ago
- More from Physics Forums - Classical Physics
More news stories
Vaccine blackjack: IL-21 critical to fight against viral infections
(Medical Xpress)—Scientists at Emory Vaccine Center have shown that an immune regulatory molecule called IL-21 is needed for long-lasting antibody responses in mice against viral infections.
Immunology
11 hours ago |
5 / 5 (1) |
0
|
Fast-acting mothers' milk for healthier babies
Human breastmilk responds quickly to protect the child when there is an infection in mothers or babies, according to new international research led by The University of Western Australia.
Immunology
11 hours ago |
5 / 5 (1) |
0
New immune system discovered
(Medical Xpress)—A research team, led by Jeremy Barr, a biology post-doctoral fellow, unveils a new immune system that protects humans and animals from infection.
Immunology
May 20, 2013 |
4.8 / 5 (25) |
8
|
Vitamin D could provide new and effective treatments for asthma
(Medical Xpress)—Scientists at King's College London have discovered that Vitamin D has the potential to significantly reduce the symptoms of asthma. The study, led by Professor Catherine Hawrylowicz from ...
Immunology
May 20, 2013 |
5 / 5 (1) |
0
|
Immune protein could stop diabetes in its tracks
Melbourne researchers have identified an immune protein that has the potential to stop or reverse the development of type 1 diabetes in its early stages, before insulin-producing cells have been destroyed.
Immunology
May 20, 2013 |
5 / 5 (5) |
0
|
Statin use is linked to increased risk of developing diabetes, warn researchers
Treatment with high potency statins (especially atorvastatin and simvastatin) may increase the risk of developing diabetes, suggests a paper published today in BMJ.
Consumers largely underestimating calorie content of fast food
People eating at fast food restaurants largely underestimate the calorie content of meals, especially large ones, according to a paper published today in BMJ.
Future doctors unaware of their obesity bias
Two out of five medical students have an unconscious bias against obese people, according to a new study by researchers at Wake Forest Baptist Medical Center. The study is published online ahead of print in the Journal of ...
WHO: Scientific red tape mars efforts vs. virus
International efforts to combat a new pneumonia-like virus that has now killed 22 people are being slowed by unclear rules and competition for the potentially profitable rights to disease samples, the head ...
Dual-source cardiac CT IDs CAD in hard-to-image patients
(HealthDay)—In patients who have previously been considered difficult to image, dual-source cardiac (DSC) computed tomography (CT) can identify clinically significant coronary artery disease, according ...
Controlling mood through the motions of mitochondria
(Medical Xpress)—Regulating the distribution of power in neurons is done by a system that makes the national electric grid look simple by comparison. Each neuron has several thousand mitochondria confined ...
Mar 13, 2012
Rank: not rated yet
Answer: The body produces a substance which stops virus' at the epidermis. Lactoferrin.
"Lactoferrin probably exerts its effect at the level of viral adsorption"
Lactoferrin removes iron , a requirement of virus , bacteria , fungi and thereby disallowing the virus to establish itself in the body.
"Antimicrobial and antiinflammatory effect of lactoferrin by chelation of iron"
When lactoferrin is partially saturated , its ability to stop the invasion is diminished greatly.
"Low iron-saturated LF effectively combats bacteria and fungi, acting in a bacteriostatic and fungistatic way. The degree of iron saturation also influences antiviral activity of LF. "
When the body has too much iron the lactoferrin becomes saturated and cannot stop the invader at the door .
Mar 13, 2012
Rank: not rated yet
Answer: The body produces a substance which stops virus' at the epidermis. Lactoferrin.
"Lactoferrin probably exerts its effect at the level of viral adsorption"
Lactoferrin removes iron , a requirement of virus , bacteria , fungi and thereby disallowing the virus to establish itself in the body.
"Antimicrobial and antiinflammatory effect of lactoferrin by chelation of iron"
When lactoferrin is partially saturated , its ability to stop the invasion is diminished greatly.
"Low iron-saturated LF effectively combats bacteria and fungi, acting in a bacteriostatic and fungistatic way. The degree of iron saturation also influences antiviral activity of LF. "
When the body has too much iron the lactoferrin becomes saturated and cannot stop the invader at the door .
Mar 13, 2012
Rank: not rated yet
Answer: High enough iron levels in the body to allow the virus' to access the iron.
"The degree of iron saturation also influences antiviral activity of LF"
Quote: Can we develop therapies to control reactivation and prevent the development of cancer ?
Answer: It has been shown in hepatitis when placed on an iron reduction treatment of phlebotomy and low-iron diet the results are a very high recovery rate and prevention of carcinoma.
"Normalization of Elevated Hepatic 8-Hydroxy-2'-Deoxyguanosine Levels in Chronic Hepatitis C Patients by Phlebotomy and Low Iron Diet"
"None of these patients developed hepatocellular carcinoma (HCC)."
"long-term iron reduction therapy in patients with chronic hepatitis C may potentially lower the risk of progression to HCC"